FDA Bioresearch Monitoring Inspection Program 2024

Speaker

Instructor: David L Chesney
Product ID: 706994
Training Level: Intermediate

Location
  • 6
  • November 2024
    Wednesday
  • 10:00 AM PT | 01:00 PM ET
    Duration: 90 Min
This webinar presents a survey of the FDA’s Bioresearch Monitoring Program, a series of FDA inspection programs covering regulatory inspections by the FDA of clinical trial sites, sponsors and Clinical Research Organizations, nonclinical testing laboratories, Institutional Review Boards (IRBs) and post marketing adverse event reporting requirements.
LIVE ONLINE TRAINING

November 06, Wednesday 10:00 AM PT | 01:00 PM ET
Duration: 90 Min

 

$199.00
One Dial-in One Attendee

$899.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

$379.00

$449.00

$249.00
1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training
(For multiple locations contact Customer Care)

$349.00
Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days after completion of Live training
(For multiple locations contact Customer Care)

 

 

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

 

The webinar will explain the scope of FDA inspection focus in each of these areas, the objectives of each, types of questions normally asked, documents typically reviewed, and specific direction to obtain copies of the relevant programs from the FDA web site.

The webinar will also present a recap of the most common inspection observations (potential violations) noted for each category of inspection, and will offer tips for inspection readiness, management and post-inspection communication with the FDA.

Why Should You Attend:

By policy, FDA pre-announces the great majority of its inspections in the bioresearch monitoring area. When companies receive such notification, the time prior to onset of the inspection is normally short, leaving little time for advance preparation. Therefore it is prudent for companies to amass the necessary understanding of the programs well ahead of experiencing an inspection. Doing so will help to minimize anxiety and reduce the chance of miscommunication or misunderstanding during the inspection. It will also help to assure that any observations made during the inspection are promptly and effectively answered within the expected time frame after conclusion of the inspection.

Areas Covered in the Webinar:

  • FDA inspection authority
  • Scope of the bioresearch monitoring programs
  • Steps in the progression of an inspection
  • Regulatory and business imperative for advance preparation and readiness
  • What to expect during the inspection
  • Where to obtain detailed information to aid in preparation, in advance
  • Common inspection observations noted
  • Effective outline for responding to any observations in writing

Who Will Benefit:

  • Executive leadership team
  • Clinical Operations
  • Clinical Quality Assurance
  • Drug safety (pharmacovigilance)
  • Medical Monitor
  • Data Management
  • Clinical Research Associates (site monitors)
  • Quality Assurance Auditors
Instructor Profile:
David L Chesney

David L Chesney
Principal and General Manager, DL Chesney Consulting LLC

David L. Chesney has a combination of 52 years experience, 23 with the FDA in an inspection and enforcement capacity, followed by over 29 years consulting experience with pharmaceutical and medical device companies world wide. He is an experienced and accomplished instructor and public speaker.

He has served as an expert witness in several private litigation matters as well as FDA court cases while with the agency. Mr. Chesney holds a BA degree in biology from California State University Northridge and an MS in Jurisprudence (pharmaceutical and medical device law) and a certificate in health care compliance from Seton Hall University School of Law.

Follow us :

 

 

Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

 

 

+1-888-717-2436

6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube

 

Copyright © 2023 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method